comparemela.com

Latest Breaking News On - Check capital management - Page 1 : comparemela.com

Cardlytics, Inc (NASDAQ:CDLX) CEO Karim Saad Temsamani Sells 43,129 Shares

Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Karim Saad Temsamani sold 43,129 shares of the business’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $8.65, for a total value of $373,065.85. Following the transaction, the chief executive officer now directly owns 385,530 shares of the […]

Heirloom Wealth Management Acquires New Position in Thermo Fisher Scientific Inc (NYSE:TMO)

Heirloom Wealth Management bought a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 377 shares of the medical research company’s stock, valued at approximately $219,000. Other large investors have […]

Berkshire Hathaway meeting: Check Capital Management CEO shares his thoughts By

Berkshire Hathaway meeting: Check Capital Management CEO shares his thoughts By
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Thermo Fisher Scientific Inc (NYSE:TMO) Shares Acquired by V Square Quantitative Management LLC

V Square Quantitative Management LLC lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 417.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,913 shares of the medical research company’s stock after purchasing an additional 1,543 shares during the quarter. […]

Thermo Fisher Scientific Inc (NYSE:TMO) Shares Purchased by Trillium Asset Management LLC

Trillium Asset Management LLC lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 1.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 92,950 shares of the medical research company’s stock after purchasing an additional 1,135 shares during […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.